Combinations of resveratrol, cisplatin and oxaliplatin applied to human ovarian cancer cells

Anticancer Research

Volumn 32, Issue 1, 2012, Pages 53-59

  Nessa, Meher U ^a   Beale, Philip ^b   Chan, Charles ^b   Yu, Jun Q ^a   Huq, Fazlul ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Department of Geriatric Medicine   (Australia)

Author keywords

Cisplatin; Drug combination; Ovarian cancer; Oxaliplatin; Resveratrol; Synergism

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CISPLATIN; OXALIPLATIN; RESVERATROL;

APOPTOSIS; ARTICLE; CANCER CELL; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; IN VIVO STUDY; OVARY CANCER; PRIORITY JOURNAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CELL LINE, TUMOR; CISPLATIN; DNA ADDUCTS; DRUG SYNERGISM; FEMALE; HUMANS; ORGANOPLATINUM COMPOUNDS; OVARIAN NEOPLASMS; STILBENES;

EID: 84862960768     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Boyle P and Levin B (eds.): World Cancer Report 2008. Lyon Cedex, France: International Agency for Research on Cancer (Part of World Health Organization), 2008.
2. Marsden DE, Friedlander M and Hacker NF: Current management of epithelial ovarian carcinoma: a review. Semin Surg Oncol 19(1): 11-19, 2000. (Pubitemid 30439310)
3. Yallapu MM, Maher DM, Sundram V, Bell MC, Jaggi M and Chauhan SC: Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth. J Ovarian Res 3(11): 1-12, 2010.
4. Kundu JK and Surh Y-J: Cancer chemopreventive and therapeutic potential of resveratrol: Mechanistic perspectives. Cancer Lett 269(2): 243-261, 2008.
5. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CWW, Fong HHS, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC and Pezzuto JM: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275(5297): 218-220, 1997. (Pubitemid 127696281)
6. Banerjee S, Padhye S, Azmi A, Wang Z, Philip PA, Kucuk O, Sarkar FH and Mohammad RM: Review on Molecular and Therapeutic Potential of Thymoquinone in Cancer. Nutr Cancer. 62(7): 938-946, 2010.
7. Solomon Leigh A, Ali S, Banerjee S, Munkarah Adnan R, Morris Robert T and Sarkar Fazlul H: Sensitization of ovarian cancer cells to cisplatin by genistein: the role of NF-kappaB. J Ovarian Res 1(9): 1-12, 2008.
8. Hu Y, Rahlfs S, Mersch-Sundermann V, Becker K, Hu Y, Rahlfs S, Mersch-Sundermann V and Becker K: Resveratrol modulates mRNA transcripts of genes related to redox metabolism and cell proliferation in non-small-cell lung carcinoma cells. Biol Chem. 388(2): 207-19, 2007. (Pubitemid 46184150)
9. Singh N, Nigam M, Ranjan V, Sharma R, Balapure AK and Rath SK: Caspase mediated enhanced apoptotic action of cyclophosphamide- and resveratrol-treated MCF-7 cells. J Pharmacol Sci 109(4): 473-485, 2009.
10. Sexton E, Van Themsche C, LeBlanc K, Parent S, Lemoine P, Asselin E, Sexton E, Van Themsche C, LeBlanc K, Parent S, Lemoine P and Asselin E: Resveratrol interferes with AKT activity and triggers apoptosis in human uterine cancer cells. Mol Cancer 5: 45 1-13, 2006.
11. Golkar L, Ding XZ, Ujiki MB, Salabat MR, Kelly DL, Scholtens D, Fought AJ, Bentrem DJ, Talamonti MS, Bell RH, Adrian TE, Golkar L, Ding X-Z, Ujiki MB, Salabat MR, Kelly DL, Scholtens D, Fought AJ, Bentrem DJ, Talamonti MS, Bell RH and Adrian TE: Resveratrol inhibits pancreatic cancer cell proliferation through transcriptional induction of macrophage inhibitory cytokine-1. J Surg Res 138(2): 163-169, 2007. (Pubitemid 46365718)
12. Bader Y and Getoff N: Effect of resveratrol and mixtures of resveratrol and mitomycin C on cancer cells under irradiation. Anticancer Res 26(6B): 4403-4408, 2006. (Pubitemid 46031514)
13. Sarkar FH, Li Y, Sarkar FH and Li Y: Using chemopreventive agents to enhance the efficacy of cancer therapy. Cancer Res 66(7): 3347-3350, 2006.
14. Yunos NM, Beale P, Yu JQ, Strain D and Huq F: Studies on combinations of platinum with paclitaxel and colchicine in ovarian cancer cell lines. Anticancer Res 30(10): 4025-4038, 2010.
15. Yunos Nurhanan M, Beale P, Yu Jun Q and Huq F: Synergism from Sequenced combinations of curcumin and epigallocatechin-3-gallate with cisplatin in the killing of human ovarian cancer cells. Anticancer Res 31(4): 1131-1140, 2011.
16. Nessa MU, Beale P, Yu JQ, Strain D and Huq F: Synergism from combinations of cisplatin and oxaliplatin with quercetin and thymoquinone in human ovarian tumour models. Anticancer Res 31: xx-xx, 2011 (in the press).
17. 2]. Indian J Chem 8: 193-194, 1970.
18. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65(1-2): 55-63, 1983.
19. Chou T-C: Relations between inhibition constants and fractional inhibition on enzyme-catalyzed reactions with different numbers of reactants, different reaction mechanisms, and different types and mechanisms of inhibition. Mol Pharmacol 10(2): 235-247, 1974.
20. Chou T-C: Derivation and properties of Michaelis-Menten type and Hill type equations for reference ligands. J Theor Biol 59(2): 253-276, 1976.
21. Di Blasi P, Bernareggi A, Beggiolin G, Piazzoni L, Menta E and Formento ML: Cytotoxicity, cellular uptake and DNA binding of the novel trinuclear platinun complex BBR 3464 in sensitive and cisplatin resistant murine leukemia cells. Anticancer Res 18(4C): 3113-3117, 1998. (Pubitemid 28388825)
22. Roberts JD, Peroutka J, Beggiolin G, Manzotti C, Piazzoni L and Farrell N: Comparison of cytotoxicity and cellular accumulation of polynuclear platinum complexes in L1210 murine leukemia cell lines. J Inorg Biochem 77(1-2): 47-50, 1999. (Pubitemid 30089081)
23. Bowtell DDL: Rapid isolation of eukaryotic DNA. Anal Biochem 162(2): 463-5, 1987.
24. Holford J, Beale PJ, Boxall FE, Sharp SY and Kelland LR: Mechanisms of drug resistance to the platinum complex ZD0473 in ovarian cancer cell lines. Eur J Cancer 36(15): 1984-1990, 2000.
25. Nobekura T, Kamiyama S and Kitagawa S: Effects of dietary chemopreventive phytochemicals on P-glycoprotein function. Biochem Biophys Res Comm 327: 866-870, 2005. (Pubitemid 40092828)